NTRB
NTRB
NASDAQ · Pharmaceuticals

Nutriband Inc

$3.11
+0.20 (+6.69%)
As of Aug 8, 10:46 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,009.6% upside
Low Target $26.32
Average Target $34.51
High Target $56.88
Current Price $3.11
Current
$3.11
Target
$34.51
$26.32 $34.51 avg $56.88
Scenario Analysis
Bear Case
$26.32
746.3%
Low target
Base Case
$34.51
+1,009.6%
Avg target
Bull Case
$56.88
+1,728.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$8.63
-63.9% from high
52-Week Low
$2.80
+11.1% from low
Target vs 52W High
$34.51
+300.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%